The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population

Thomas, G. Neil; Ho, Sai-Yin; Janus, Edward; Lam, Karen S.L.; Hedley, A. J.; Lam, Tai Hing

doi:10.1016/j.diabres.2004.07.022

Cited by 148 publications

(106 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In general, the prevalence of obesity, low HDL and hyperglycemia were higher in women, and high blood pressure and hypertriglyceridemai were higher in men (Ford et al, 2002;Gupta et al, 2004;Thomas et al, 2005). The most striking gender difference among components of MS in our population was the frequency of abdominal obesity.…”

Section: Components Of Msmentioning

confidence: 58%

“…Therefore, the differences may in part be due Our results demonstrate a remarkably higher prevalence of MS in Turkish population when using the ATP III definition. The prevalence is higher when compared with Americans, Koreans, Chinese, Japanese, Mongolians (Ford et al, 2002;Kim et al, 2004;Lee et al, 2004;Duc Son et al, 2005;Enkhmaaa et al, 2005;Thomas et al, 2005) and comparable to that of Mexican Americans, South Asians and Persians (Ford et al, 2002;Azizi et al, 2003;Ramachandran et al, 2003;Gupta et al, 2004). Turkish population has one of the world's highest prevalences of MS, comparable to that of the South Asians.…”

Section: Ethnic and Country Differences In Ms Prevalencementioning

confidence: 93%

“…In some countries, MS is more prevalent among women (Ramachandran et al, 2003;Gupta et al, 2004;Kim et al, 2004;Lee et al, 2004), in others, the prevalence of the syndrome is similar in two sexes (Chuang et al, 2004;Duc Son et al, 2005;Enkhmaaa et al, 2005;Thomas et al, 2005). The prevalence differed little among men and women in the USA.…”

Section: Ethnic and Country Differences In Ms Prevalencementioning

confidence: 99%

“…Studies performed in various ethnic groups have also shown that the frequency of individual components of MS can vary between countries and ethnic groups (Ford et al, 2002;Onat and Sansoy, 2002;Azizi et al, 2003;Ramachandran et al, 2003;Chuang et al, 2004;Gupta et al, 2004;Kim et al, 2004;Lee et al, 2004;Duc Son et al, 2005;Enkhmaaa et al, 2005;Thomas et al, 2005). Genetic factors may also have a role in determining the different clustering of various components of the MS in various individuals and ethnic groups (Abate, 2000;Thomas et al, 2000).…”

Section: Components Of Msmentioning

confidence: 99%

“…Although obesity and level of physical activity contribute significantly to the frequency of MS, other factors, such as a genetic predisposition, may play a role (Abate, 2000;Thomas et al, 2000;Das, 2002). Studies performed in various ethnic groups have also shown that the frequency of individual components of MS can vary between countries (Ford et al, 2002;Onat and Sansoy, 2002;Azizi et al, 2003;Ramachandran et al, 2003;Chuang et al, 2004;Gupta et al, 2004;Kim et al, 2004;Lee et al, 2004;Duc Son et al, 2005;Enkhmaaa et al, 2005;Thomas et al, 2005).…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Prevalence of the metabolic syndrome among Turkish adults

Oğuz²,

et al. 2006

View full text Add to dashboard Cite

Objective: To determine prevalence of the metabolic syndrome (MS) in a sample representing Turkish population using United States Adult Treatment Panel-3 guidelines. Design: The study included random samples from both urban and rural populations in the seven geographical regions of Turkey. The population for this analysis were 2108 men (1372 in urban and 736 in rural areas) and 2151 women (1423 in urban and 728 in rural areas) with a mean age of 40.9714.9 years (range 20-90). Results: The prevalence of the MS diagnosed using the Adult Treatment Panel III criteria was 33.9% (1442 of 4259) and differed significantly in men (28%) and women (39.6%). The prevalence of syndrome increased with age in men, from 10.7% in subjects aged 20-29 years to 49% in those aged over 70 years. The prevalence increased with age in women, from 9.6% in subjects aged 20-29 years to 74.6% in those aged 60-69 years, and decreased to 68.6% in those over 70 years of age. The prevalence of the syndrome was similar in urban (33.8%) and rural (33.9%) population. We found 26.8, 26.4, 19.3, 10.9 and 3.6% of the population had at least 1, 2, 3, 4 or 5 components, respectively. We found 57.2, 32.3 and 10.6% of the subjects with MS had 3, 4 and 5 components, respectively.

show abstract

Section: Components Of Msmentioning

confidence: 58%

Section: Ethnic and Country Differences In Ms Prevalencementioning

confidence: 93%

Section: Ethnic and Country Differences In Ms Prevalencementioning

confidence: 99%

Section: Components Of Msmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Prevalence of the metabolic syndrome among Turkish adults

Oğuz²,

et al. 2006

View full text Add to dashboard Cite

show abstract

Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis

Mok

et al. 2011

Arthritis Care & Research

173

148

View full text Add to dashboard Cite

Objective. To evaluate the prevalence of the metabolic syndrome in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA). Methods. Consecutive patients with RA, AS, or PsA who attended our outpatient arthritis clinics between July and November 2009 were recruited for a study of atherosclerotic risk factors and the metabolic syndrome, defined according to the 2009 joint statements using the Asian criteria for central obesity. Results. Nine hundred thirty patients were studied (699 with RA, 122 with AS, and 109 with PsA; 70% women, mean ؎ SD age 51.1 ؎ 12.7 years). The mean ؎ SD disease duration for patients with RA, AS, and PsA was 5.3 ؎ 5.4, 6.0 ؎ 5.6, and 3.6 ؎ 3.1 years, respectively. The prevalence of metabolic syndrome was significantly higher in PsA (38%) than RA (20%) or AS (11%; P < 0.001). The odds ratios (ORs) for the metabolic syndrome compared to age-and sex-matched controls were 0.98 (95% confidence interval [95% CI] 0.78 -1.23, P ‫؍‬ 0.88), 0.59 (95% CI 0.30 -1.15, P ‫؍‬ 0.12), and 2.68 (95% CI 1.60 -4.50, P < 0.001), respectively, for RA, AS, and PsA. Patients with PsA had a significantly higher prevalence of impaired fasting glucose (30%; P < 0.001), low high-density lipoprotein (HDL) cholesterol (33%; P < 0.001), high triglycerides level (21%; P ‫؍‬ 0.008), central obesity (65%; P < 0.001), and high blood pressure (56%; P ‫؍‬ 0.045). In a logistic regression model, the adjusted OR for the metabolic syndrome in PsA was 2.44 (95% CI 1.48 -4.01, P < 0.001) relative to RA or AS. The adjusted ORs for central obesity, impaired fasting glucose, hypertriglyceridemia, and low HDL cholesterol were also significantly higher in PsA patients. Conclusion. Patients with PsA, but not RA or AS, have a significantly higher prevalence of the metabolic syndrome compared to the general population. Among the 3 diseases studied, PsA has the highest prevalence of the metabolic syndrome and is associated with the highest cardiovascular risk.

show abstract

Current literature in diabetes

2005

Diabetes Metabolism Res

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of diabetes/metabolism. Each bibliography is divided into 26 sections: 1 Reviews & Symposia; 2 General; 3 Genetics; 4 Epidemiology; 5 Immunology; 6 Obesity; 7 Prediction and Prevention; 8 Intervention: a) General; b) Care; c) Drug Therapy; d)Economics; e) Gene therapy; f) Nursing; g) Nutrition; h) Surgery; i) Transplantation; 9 Pathology and Complications: a) General; b) Cardiovascular; c) Eye disease; d) Gestational and fetal; e) Neurological; f) Podiatrical; g) Renal; 10 Endocrinology & Metabolism; 11 Experimental Studies; 12 Diagnosis and Techniques. Within each section, articles are listed in alphabetical order with respect to author

show abstract

The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population

Cited by 148 publications

References 18 publications

Prevalence of the metabolic syndrome among Turkish adults

Prevalence of the metabolic syndrome among Turkish adults

Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis

Current literature in diabetes

Contact Info

Product

Resources

About